Dosimetry for 177Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer
2015 · European Journal of Nuclear Medicine and Molecular Imaging · 310 citations
https://doi.org/10.1007/s00259-015-3174-7
P
Peter Bartenstein
LMU Klinikum(DE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
668
Papers
21.3K
Citations
74
h-index
340
i10-index
Peter Bartenstein is an academic researcher from LMU Klinikum. The author has contributed to research in topics: Medical Imaging Techniques and Applications & Radiopharmaceutical Chemistry and Applications & Alzheimer's disease research and treatments. The author has an h-index of 74, co-authored 568 publications.
ORCID: 0009-0005-0734-4994Papers by this author
worksNasal high flow reduces dead space
2016 · Journal of Applied Physiology · 248 citations
https://doi.org/10.1152/japplphysiol.00584.2016
First Clinical Results for PSMA-Targeted α-Therapy Using <sup>225</sup>Ac-PSMA-I&T in Advanced-mCRPC Patients
2020 · Journal of Nuclear Medicine · 172 citations
https://doi.org/10.2967/jnumed.120.251017
[68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning
2009 · Radiation Oncology · 140 citations
https://doi.org/10.1186/1748-717x-4-56
Recent advances of PET imaging in clinical radiation oncology
2020 · Radiation Oncology · 125 citations
https://doi.org/10.1186/s13014-020-01519-1
<sup>18</sup>F-FDG PET/CT Predicts Survival After Radioembolization of Hepatic Metastases from Breast Cancer
2012 · Journal of Nuclear Medicine · 106 citations
https://doi.org/10.2967/jnumed.111.096230
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat